Study of the Safety and Efficacy of Prenofitol Tablets
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.
Also called NCT07908433
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Registry
-
NCT07908433
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07908433. Randomized; quadruple masking; primary purpose prevention. Start 2026-11-02 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of the Safety and Efficacy of Prenofitol Tablets
- Condition
- Dyslipidemia
- Intervention (Drug)
- 1 tablet of Prenofitol
- Intervention (Drug)
- 2 tablets of Prenofitol
- Intervention (Drug)
- 1 tablet of placebo
- Intervention (Drug)
- 2 tablets of placebo
- Lead sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Record details
- Record id
cardio:ct-nct07908433- Content hash
10ec68a3a652042a68e77b0edb3f647dd583f11fb22d43b50e824ff265ca712d